Clinical and genetic characteristics of CSF1R-related leukoencephalopathy: a retrospective analysis of three cases
Neurogenetics · 18.05.2026 · 27 (1)
DOI: 10.1007/s10048-026-00907-1 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurogenetics, online erschienen am 18.05.2026. Verfasst von Sifen Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Guangdong Sanjiu Brain Hospital, Guangzhou, China. Hauptthemen laut MEDLINE: Leukoencephalopathies, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Guangdong Medical Scientific Research Foundation.
Abstract (Originalsprache)
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal dominant neurodegenerative disorder caused by CSF1R variants, which lead to microglial dysfunction and progressive white matter degeneration. This study identified CSF1R variants in three unrelated Chinese patients with HDLS. We identified heterozygous CSF1R variants (NM_001288705.3) in three unrelated Chinese patients with HDLS: c.2522 A > C/p.(Tyr841Ser), c.2442 + 1G > A/p.?, and c.2546_2548del/p.(Phe849del). While the former two variants were categorized as likely pathogenic under the American College of Medical Genetics and Genomics framework, the latter (c.2546_2548del) was classified as a variant of uncertain significance due to insufficient evidence at the time of analysis. All patients exhibited cognitive decline, personality changes, and motor symptoms. Brain MRI showed characteristic diffuse white matter hyperintensities, restricted diffusion, corpus callosum atrophy, and brain atrophy. Symptoms progressed in Patient 1 (c.2522 A > C p.(Tyr841Ser)) and Patient 3 (c.2546_2548del p.(Phe849del)) despite standard symptomatic treatments. Clinical status remained relatively stable in Patient 2 (c.2442 + 1G > A/p.?) following allogeneic hematopoietic stem cell transplantation (HSCT). These findings expand the molecular and clinical spectrum of CSF1R in Chinese populations and highlight the diagnostic value of genetic sequencing in adult-onset leukoencephalopathies. Establishing a precise molecular diagnosis is crucial, as allogeneic HSCT remains a potentially disease-modifying therapy for patients with CSF1R-related leukoencephalopathy. Further longitudinal studies are warranted to evaluate the long-term efficacy of HSCT and to explore emerging targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
- Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guang…
- Department of Neurology, Guangdong Sanjiu Brain Hospital, Guangzhou, China. kedafu2005@sina.com.
- Department of Neurology, Guangdong Sanjiu Brain Hospital, Guangzhou, China. kuangzuying403@163.com.
Förderung
- Guangdong Medical Scientific Research Foundation
Zitieren
APA
Xie, S., Yang, Q., Pan, M., Hu, Y., Huang, N., Chen, Z., Ye, J., Luo, S., Wang, Z., & Kuang, Z. (2026). Clinical and genetic characteristics of CSF1R-related leukoencephalopathy: a retrospective analysis of three cases. Neurogenetics, 27(1). https://doi.org/10.1007/s10048-026-00907-1
Vancouver
Xie S, Yang Q, Pan M, Hu Y, Huang N, Chen Z, et al. Clinical and genetic characteristics of CSF1R-related leukoencephalopathy: a retrospective analysis of three cases. Neurogenetics. 2026;27(1). doi:10.1007/s10048-026-00907-1
BibTeX
@article{Xie2026,
author = {Xie, Sifen and Yang, Qiqiong and Pan, Mengqiu and Hu, Yepeng and Huang, Nayang and Chen, Zhongjie and Ye, Jinlong and Luo, Sheng and Wang, Zhanhang and Kuang, Zuying},
title = {Clinical and genetic characteristics of CSF1R-related leukoencephalopathy: a retrospective analysis of three cases},
journal = {Neurogenetics},
year = {2026},
volume = {27},
number = {1},
doi = {10.1007/s10048-026-00907-1}
}
EUVIMED